Venous Thromboembolism

Patients with multiple myeloma who received lenalidomide-based regimens appeared to have considerable risk for venous thromboembolism, regardless of adequate thromboprophylaxis, according to study results published in Cancer.

An analysis of the ongoing SAGE-AF trial revealed that approximately 23% of geriatric patients with atrial fibrillation and prescribed a direct oral anticoagulant received inappropriate dosing.

Results of a study comparing outcomes of total knee arthroplasty procedures performed for osteoarthritis and post-traumatic arthritis have shown the incidence of superficial wound infection, deep joint infection and acute deep venous thrombosis occurs at a higher rate in patients with post-traumatic arthritis. However, the incidence of pulmonary embolus was not statistically different between the two groups.

Several algorithms identified oral anticoagulation prescriptions given in the ED for patients with atrial fibrillation, according to a study published in JAMA Network Open.

ORLANDO — More than one in 10 patients with lymphoma who underwent chimeric antigen receptor T-cell therapy developed new venous thromboembolism, according to study results presented at TCT | Transplantation & Cellular Therapy Meetings.

The International Symposium on Endovascular Therapy, held Jan. 22 to 25 in Hollywood, Florida, tackled many of the hottest topics in endovascular intervention. To obtain the key take-home messages from ISET 2020, Healio spoke with experts in the field including Robert Lookstein, MD, MHCDL, FSIR, FAHA, FSVM, from Mount Sinai Health System; Jihad A. Mustapha, MD, FACC, FSCAI, from Advanced Cardiac and Vascular Centers for Amputation Prevention in Grand Rapids, Michigan, and Michigan State University College of Osteopathic Medicine; Constantino S. Peña, MD, FAHA, FSCCT, FSIR, from Miami Cardiac and Vascular Institute and Florida International University Herbert Wertheim College of Medicine; and Kenneth Rosenfield, MD, MHCDS, FACC, FAHA, MSCAI, from Massachusetts General Hospital.

The American College of Cardiology has announced the lineup of late-breaking clinical trials scheduled for presentation at the 2020 Scientific Session.

Aspirin was not statistically significantly different from other anticoagulants when used for venous thromboembolism prophylaxis after either total hip replacement or total knee replacement with regard to its clinical effectiveness and safety profile, according to published results.

Children with peripherally inserted central catheters demonstrated a significantly higher risk for venous thromboembolism, central line-associated bloodstream infections and catheter malfunctions than children with centrally inserted tunneled lines, according to a new analysis of data from the CIRCLE study published in Blood.

Published results showed certain preoperative and postoperative doses of osocimab used in patients undergoing unilateral knee arthroplasty met noninferiority and superiority criteria for the incidence of venous thromboembolism compared with enoxaparin.